Juan Wu

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

Bart L. Scott, Marcelo C. Pasquini, Brent R. Logan et al. · Journal of Clinical Oncology · 2017 · 649 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Optimal Regimen Intensity +16

Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis

Javier Bolaños‐Meade, Mehdi Hamadani, Juan Wu et al. · New England Journal of Medicine · 2023 · 460 citations · Full text

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)

Javier Bolaños‐Meade, Ran Reshef, Raphael Fraser et al. · The Lancet Haematology · 2019 · 274 citations

Versus Tacrolimus, Transplantation, Immunosuppressive Therapy +9

Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT

Corey Cutler, Brent R. Logan, Ryotaro Nakamura et al. · Blood · 2014 · 215 citations · Full text

A trial of unrelated donor marrow transplantation for children with severe sickle cell disease

Shalini Shenoy, Mary Eapen, Julie A. Panepinto et al. · Blood · 2016 · 206 citations · Full text